关注
Ke Wang
Ke Wang
University of Wisconsin-Madison and Fudan University
在 wisc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Novel nitric oxide donors of phenylsulfonylfuroxan and 3-benzyl coumarin derivatives as potent antitumor agents
Y Guo, Y Wang, H Li, K Wang, Q Wan, J Li, Y Zhou, Y Chen
ACS Medicinal Chemistry Letters 9 (5), 502-506, 2018
482018
A novel hybrid of 3-benzyl coumarin seco-B-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer
M Dong, T Ye, Y Bi, Q Wang, K Kuerban, J Li, M Feng, K Wang, Y Chen, ...
Phytomedicine 52, 79-88, 2019
192019
Novel hybrids of 3-substituted coumarin and phenylsulfonylfuroxan as potent antitumor agents with collateral sensitivity against MCF-7/ADR
Z Yu, M Li, K Wang, Y Gu, S Guo, W Wang, Y Ma, H Liu, Y Chen
Journal of Medicinal Chemistry 65 (13), 9328-9349, 2022
152022
Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives
H Li, K Wang, Q Wan, Y Chen
Steroids 141, 81-95, 2019
132019
Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds
GQ Gong, K Wang, XC Dai, Y Zhou, R Basnet, Y Chen, DH Yang, WJ Lee, ...
Acta Pharmacologica Sinica 39 (12), 1902-1912, 2018
132018
Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and estradiol derivatives
Q Wan, Y Deng, Y Huang, Z Yu, C Wang, K Wang, J Dong, Y Chen
ChemistryOpen 9 (2), 176-182, 2020
102020
Seco-4-methyl-DCK derivatives as potent chemosensitizers
Y Guo, K Wang, X Chen, H Li, Q Wan, S Morris-Natschke, KH Lee, ...
Bioorganic & Medicinal Chemistry Letters 29 (1), 28-31, 2019
32019
Coumarin–Furoxan Hybrid Suppressed the Proliferation and Metastasis of Triple-Negative Breast Cancer by Activating Mitochondrial Stress and Cell Apoptosis
M Li, F Cao, W Wang, Y Ma, Z Yu, K Wang, Y Chen, H Liu
ACS Pharmacology & Translational Science 7 (5), 1278-1290, 2024
12024
Introduction of Mercaptoethyl at Sorafenib Pyridine-2-Amide Motif as a Potentially Effective Chain to Further get Sorafenib-PEG-DGL
K Wang, K Kuerbana, Q Wan, Z Yu, L Ye, Y Chen
Molecules 25 (3), 573, 2020
12020
The non-catalytic domains of O-GlcNAc cycling enzymes present new opportunities for function-specific control
CW Hu, K Wang, J Jiang
Current Opinion in Chemical Biology 81, 102476, 2024
2024
Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model
Y Yuan, Z Li, K Wang, S Zhang, Q He, L Liu, Z Tang, X Zhu, Y Chen, ...
Molecules 28 (2), 837, 2023
2023
NO donor coumarin furazan conjugate and pharmaceutical application thereof
C YING, W KE, YU ZHIHUI
CN Patent CN113,493,449 A, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–12